Manufacturing and Production

Showing 15 posts of 5871 posts found.

Shanghai China flag

Betting big on research in China

September 13, 2011 Manufacturing and Production, Research and Development China, R&D

For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – …

AM-Pharma appoints new chief executive

September 13, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Dutch biopharmaceutical company AM-Pharma has appointed Erik van den Berg as its new chief executive. He was previously VP business …
Genzyme

Genzyme confirms further Fabrazyme delay

September 13, 2011 Manufacturing and Production Fabrazyme, Genzyme, pharma manufacturing news

Genzyme has been forced to delay shipments of its Fabry disease treatment Fabrazyme once again, blaming its “quality release process”. …

Slow Provenge growth prompts Dendreon staff cull

September 13, 2011 Business Services, Manufacturing and Production Dendreon, Provenge, job cuts, pharma manufacturing news

After months of building manufacturing capacity, US biotech Dendreon has decided to slash a quarter of its workforce – with …

Aurobindo forms Russian joint venture with Diod

September 13, 2011 Manufacturing and Production, Sales and Marketing Aurobindo, Diod, pharma manufacturing news

Indian drugmaker Aurobindo has formed a joint venture with Russia’s OJSC Diod in order to tap into the local market …

Offshoring pharma manufacturing increases risk, says study

September 12, 2011 Manufacturing and Production Puerto Rico, contract manufacturing, pharma manufacturing news

Drugs produced in offshore manufacturing plants – even those run by US manufacturers – pose a greater quality risk than …

Pharma manufacturing news in brief

September 12, 2011 Manufacturing and Production pharma manufacturing news

DMV-Fonterra agrees to buy India’s Brahmar Cellulose, plus there are facility updates from Reliable and Toyoba, some bad press for …

Dendreon drops GSK as Provenge manufacturing partner

September 8, 2011 Manufacturing and Production Dendreon, GSK, Provenge, pharma manufacturing news

Dendreon has called a halt to its manufacturing and supply deal with GlaxoSmithKline for cancer vaccine Provenge, citing “delays and …

Lilly considering a stake in Turkish drugmaker

September 6, 2011 Manufacturing and Production, Research and Development, Sales and Marketing MN Pharmaceuticals, Turkey, lilly, research and development news

Eli Lilly is reportedly eyeing up a partnership with Turkish drugmaker Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals) in order to …

New API production process ‘could transform pharma’

September 6, 2011 Manufacturing and Production pharma manufacturing news, pharma production

UK researchers have started work on a new project to examine a new production method that they claim could “significantly …

CSL vaccine probe likely to rule out manufacturing errors

September 6, 2011 Manufacturing and Production CSL Biotherapies, flu, pharma manufacturing news, vaccines

CSL Biotherapies has said that manufacturing errors were likely not to blame for febrile seizures in children who received its …

Pharma manufacturing news in brief

September 6, 2011 Manufacturing and Production pharma manufacturing news

USP expands operations in India, DSM gets green light for Chinese anti-infective joint venture, plus there are updates from CMC …

Teva in the dock again for hepatitis link to propofol

August 30, 2011 Manufacturing and Production Teva, manufacturing and production news, propofol

Teva’s decision to shut down a manufacturing facility for the anaesthetic propofol has become a focal point in a US …

GE gets bigger in upstream bioprocessing with PAA Labs buy

August 30, 2011 Manufacturing and Production GE Healthcare, PAA Labs, manufacturing and production news

General Electric unit GE Healthcare has continued to expand its life sciences business with an agreement to buy privately-held PAA …

Catalent to buy Aptuit and claim number two spot in clinical supply

August 30, 2011 Manufacturing and Production Aptuit, Catalent, manufacturing and production news

Catalent Pharma Solutions has agreed to purchase the clinical trial supply business of Aptuit in a $410 million deal which …
The Gateway to Local Adoption Series

Latest content